Biondo Investment Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$10.5M |
| 2 |
ExxonMobil
XOM
|
+$4.22M |
| 3 |
Align Technology
ALGN
|
+$3.42M |
| 4 |
Boeing
BA
|
+$2.12M |
| 5 |
SIVB
SVB Financial Group
SIVB
|
+$1.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$5.18M |
| 2 |
MZOR
Mazor Robotics Ltd.
MZOR
|
+$4.96M |
| 3 |
Phillips 66
PSX
|
+$4.84M |
| 4 |
Alibaba
BABA
|
+$4.4M |
| 5 |
Intuitive Surgical
ISRG
|
+$3.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.65% |
| 2 | Financials | 13.89% |
| 3 | Technology | 11.7% |
| 4 | Consumer Discretionary | 7.4% |
| 5 | Communication Services | 6.61% |
Similar funds
Biondo Investment Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, Biondo Investment Advisors held 87 positions worth $331M, down 21% from $421M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Biondo Investment Advisors withdrew a net $15.3M in Q4 2018, closing 8 positions and reducing 47 holdings. Its most notable exit was SLB Ltd, an estimated $5.18M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Financials and Technology.
Against the trend, Biondo Investment Advisors opened a new position in iShares MSCI EAFE ETF worth $9.86M.
- Biondo Investment Advisors's largest Q4 2018 buy was iShares MSCI EAFE ETF: 167,725 shares worth $9.86M.
- Biondo Investment Advisors added most to ExxonMobil in Q4 2018, an estimated $4.22M increase.
- Biondo Investment Advisors's biggest Q4 2018 reduction was Alibaba, cutting an estimated $4.4M.
- Biondo Investment Advisors fully exited SLB Ltd in Q4 2018, selling an estimated $5.18M.
- Biondo Investment Advisors's ten largest holdings make up 52% of its $331M portfolio in Q4 2018.
- Biondo Investment Advisors opened 7 new positions and closed 8 in Q4 2018.
- Biondo Investment Advisors's portfolio value fell 21% quarter-over-quarter to $331M.
Based on Biondo Investment Advisors's 13F filing for Q4 2018, filed 8 Feb 2019.